Patents by Inventor Pascale Mauvais

Pascale Mauvais has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenol derivatives and the pharmaceutical or cosmetic use thereof
    Patent number: 10202346
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: July 27, 2015
    Date of Patent: February 12, 2019
    Assignee: Galderma Research & Development
    Inventors: Cedric Poinsard, Pascal Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics
    Patent number: 9630949
    Abstract: The present invention relates to novel compounds derived from oxoazetidine corresponding to general formula (I) to the compositions containing same, to the process for preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: April 25, 2017
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Nicolas Rodeville, Pascale Mauvais, Jean-Claude Pascal
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20170037015
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: October 20, 2016
    Publication date: February 9, 2017
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9505720
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: November 29, 2016
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascal Collette, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais
  • NOVEL PHENOL DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160115132
    Abstract: The present invention relates to novel compounds of general formula: and to the cosmetic or pharmaceutical use thereof.
    Type: Application
    Filed: May 8, 2015
    Publication date: April 28, 2016
    Inventors: Cédric POINSARD, Pascal COLLETTE, Jean-Michel LINGET, Sandrine RETHORE, Pascale MAUVAIS
  • PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20160068488
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: July 27, 2015
    Publication date: March 10, 2016
    Inventors: Cedric POINSARD, Pascal COLLETTE, Pascale MAUVAIS, Jean-Michel LINGET, Sandrine RETHORE
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9120753
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: September 1, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore
  • Phenol derivatives and pharmaceutical or cosmetic use thereof
    Patent number: 9050266
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: June 9, 2015
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Jean-Michel Linget, Sandrine Rethore, Pascale Mauvais, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS
    Publication number: 20150045559
    Abstract: The present invention relates to novel compounds derived from oxoazetidine corresponding to general formula (I) to the compositions containing same, to the process for preparation thereof and to the use thereof in pharmaceutical or cosmetic compositions.
    Type: Application
    Filed: September 26, 2014
    Publication date: February 12, 2015
    Inventors: Claire BOUIX-PETER, Itaru SUZUKI, Nicolas RODEVILLE, Pascale MAUVAIS, Jean-Claude PASCAL
  • Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
    Patent number: 8871187
    Abstract: Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.
    Type: Grant
    Filed: November 4, 2009
    Date of Patent: October 28, 2014
    Assignee: Galderma Research & Development
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Nicolas Rodeville, Pascale Mauvais, Jean-Claude Pascal
  • Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
    Patent number: 8772478
    Abstract: Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Grant
    Filed: June 28, 2010
    Date of Patent: July 8, 2014
    Assignee: Galderma Research & Development
    Inventors: Laurence Clary, Sandrine Chambon, Laurent Chantalat, Pascale Mauvais, Olivier Roye, Marlène Schuppli
  • PHENOL DERIVATIVES AND THE PHARMACEUTICAL OR COSMETIC USE THEREOF
    Publication number: 20130178633
    Abstract: The use of compounds in the treatment of skin disorders is described. In particular, use of a compound of formula (I): or one of its pharmaceutically acceptable salts, solvates or hydrates in the preparation of a medicament to treat skin pathologies is described.
    Type: Application
    Filed: December 22, 2010
    Publication date: July 11, 2013
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Cédric Poinsard, Pascale Mauvais, Jean-Michel Linget, Sandrine Rethore, Patrice Lucien Maurice Collette, Isabelle Marie Joëlle Martine Collette
  • NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS
    Publication number: 20120116072
    Abstract: Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.
    Type: Application
    Filed: June 28, 2010
    Publication date: May 10, 2012
    Inventors: Laurence Clary, Sandrine Chambon, Laurent Chantalat, Pascale Mauvais, Olivier Roye, Marlene Schuppli
  • OXOAZETIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND USE THEREON IN HUMAN MEDICINE AND IN COSMETICS
    Publication number: 20110274638
    Abstract: Compounds derived from oxoazetidine corresponding to general formula (I) compositions containing same, processes for their preparation and their use in pharmaceutical or cosmetic compositions are described.
    Type: Application
    Filed: November 4, 2009
    Publication date: November 10, 2011
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Bouix-Peter, Itaru Suzuki, Nicolas Rodeville, Pascale Mauvais, Jean-Claude Pascal
  • Methods for activating PPAR gamma-type receptors
    Patent number: 7973063
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: October 9, 2009
    Date of Patent: July 5, 2011
    Assignee: Galderma Research & Development
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Methods for activating PPAR gamma-type receptors
    Publication number: 20100035988
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: October 9, 2009
    Publication date: February 11, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Biaromatic compounds which activate PPAR?-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Patent number: 7626054
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Grant
    Filed: November 3, 2006
    Date of Patent: December 1, 2009
    Assignee: Galderma Research & Development
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Novel biaromatic compounds which activate PPARy-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20070112070
    Abstract: Novel biaromatic compounds having the following structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine, in particular in dermatology as well as in the fields of cardiovascular diseases, immune diseases and/or diseases related to the metabolism of lipids, or, alternatively, into cosmetic compositions.
    Type: Application
    Filed: November 3, 2006
    Publication date: May 17, 2007
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Jerome Aubert, Laurence Clary, Pascale Mauvais, Michel Rivier, Etienne Thoreau, Jean-Guy Boiteau
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060052627
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 9, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel
  • Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereof
    Publication number: 20060035969
    Abstract: Novel compounds which modulate PPAR-type receptors have the following general formula (I): and are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology and in the fields of cardiovascular diseases, immune diseases and/or diseases linked to lipid metabolism), or are formulated into cosmetic compositions.
    Type: Application
    Filed: August 12, 2005
    Publication date: February 16, 2006
    Applicant: GALDERMA RESEARCH & DEVELOPMENT, S.N.C.
    Inventors: Philippe Diaz, Etienne Thoreau, Isabelle Carlavan, Pascale Mauvais, Johannes Voegel